SCIENTIFIC BACKGROUND

G6PD

Favism (from Latin: faba = bean) is an X-linked recessive inherited metabolic disease caused by a glucose-6-phosphate dehydrogenase (G6PD) deficiency. The enzyme glucose-6-phosphate dehydrogenase plays a key role in the pentose phosphate pathway and catalyzes the conversion of glucose-6-phosphate to D-glucono-1,5-lactono-6-phosphate. This produces reduction equivalents such as NADPH that protect certain cell structures (e.g., erythrocyte membranes) from oxidative damage. The cell loses this protective mechanism due to the G6PD enzyme deficiency and hemolytic anemia occurs.

 

Various pathogenic variants in the G6PD gene lead to G6PD deficiency. The residual enzymatic activity and thus the symptom expression varies depending on the variant. G6PD deficiency is divided into different classes according to the enzyme activity measured.

 

Due to the X-linked chromosomal inheritance, it is mainly men who are affected. Hemizygous men and homozygous or combined heterozygous women with variants on the X chromosome show the fully developed phenotype. Heterozygous female carriers usually show symptoms only if there is a preferential expression of the allele in question, e.g., due to delayed X-inactivation. The prevalence is 0.14-0.37% among the German population, and 3-35% in some countries of the Mediterranean, Africa and Asia. In the Western European population, the Mediterranean form caused by variant c.563C>T [p.(Ser188Phe)] is the most common cause of favism, and it leads to a severe form of the disease (WHO class II). Drugs with an oxidative effect can trigger hemolytic-anemic crises and should only be prescribed after a thorough risk-benefit analysis. Fava bean proteins (aglycones) and its pollen also trigger hemolytic events.

 

References

Belfield and Tichy 2018, Am J Health Syst Pharm 75:97 / Minucci et al. 2009, IUBMB Life, 61: 27 / Turan 2006, Archives of Medical Research 37:880 / Beutler and Vulliamy 2002, Blood Cells Mol Dis 28:93 / Vulliamy et al. 1988, Proc Nat Acad Sci 85:571 / www.favismus.de

GENES

G6PD

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more